Association between ultrarapid CYP2D6 polymorphisms and adverse drug reactions among women with breast cancer treated with tamoxifen

Roberta ROLLA; M. Vidali; S. Meola; P. Pollarolo; M. R. Fanello; C. Nicolotti; L. Forti; G. Borra; F. D’Agostino; V. Rossi; ALABISO Oscar; BELLOMO Giorgio

Association between ultrarapid CYP2D6 polymorphisms and adverse drug reactions among women with breast cancer treated with tamoxifen

Roberta ROLLA, M. Vidali, S. Meola, P. Pollarolo, M. R. Fanello, C. Nicolotti, L. Forti, G. Borra, F. D’Agostino, V. Rossi, ALABISO Oscar, BELLOMO Giorgio

Dipartimento di Scienze della Salute

Risultato della ricerca: Contributo alla conferenza › Contributo in Atti di Convegno

Lingua originale	Italian
Stato di pubblicazione	Pubblicato - 1 gen 2011
Evento	IFCC-WorldLab 21st International Congress of Clinical Chemistry and Laboratory Medicine - Berlin, Germany Durata: 1 gen 2011 → …

???event.eventtypes.event.conference???

???event.eventtypes.event.conference???	IFCC-WorldLab 21st International Congress of Clinical Chemistry and Laboratory Medicine
Città	Berlin, Germany
Periodo	1/01/11 → …

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Altri file e collegamenti

handle

Cita questo

ROLLA, R., Vidali, M., Meola, S., Pollarolo, P., Fanello, M. R., Nicolotti, C., Forti, L., Borra, G., D’Agostino, F., Rossi, V., Oscar, ALABISO., & Giorgio, BELLOMO. (2011). Association between ultrarapid CYP2D6 polymorphisms and adverse drug reactions among women with breast cancer treated with tamoxifen. Articolo presentato al IFCC-WorldLab 21st International Congress of Clinical Chemistry and Laboratory Medicine, Berlin, Germany.

@conference{272e89e816d84ef890f5811c05cfeccd,

title = "Association between ultrarapid CYP2D6 polymorphisms and adverse drug reactions among women with breast cancer treated with tamoxifen",

author = "Roberta ROLLA and M. Vidali and S. Meola and P. Pollarolo and Fanello, {M. R.} and C. Nicolotti and L. Forti and G. Borra and F. D{\textquoteright}Agostino and V. Rossi and ALABISO Oscar and BELLOMO Giorgio",

year = "2011",

month = jan,

day = "1",

language = "Italian",

note = "IFCC-WorldLab 21st International Congress of Clinical Chemistry and Laboratory Medicine ; Conference date: 01-01-2011",

}

ROLLA, R, Vidali, M, Meola, S, Pollarolo, P, Fanello, MR, Nicolotti, C, Forti, L, Borra, G, D’Agostino, F, Rossi, V, Oscar, ALABISO & Giorgio, BELLOMO 2011, 'Association between ultrarapid CYP2D6 polymorphisms and adverse drug reactions among women with breast cancer treated with tamoxifen', Articolo presentato al IFCC-WorldLab 21st International Congress of Clinical Chemistry and Laboratory Medicine, Berlin, Germany, 1/01/11.

Association between ultrarapid CYP2D6 polymorphisms and adverse drug reactions among women with breast cancer treated with tamoxifen. / ROLLA, Roberta; Vidali, M.; Meola, S. et al.
2011. Articolo presentato al IFCC-WorldLab 21st International Congress of Clinical Chemistry and Laboratory Medicine, Berlin, Germany.

Risultato della ricerca: Contributo alla conferenza › Contributo in Atti di Convegno

TY - CONF

T1 - Association between ultrarapid CYP2D6 polymorphisms and adverse drug reactions among women with breast cancer treated with tamoxifen

AU - ROLLA, Roberta

AU - Vidali, M.

AU - Meola, S.

AU - Pollarolo, P.

AU - Fanello, M. R.

AU - Nicolotti, C.

AU - Forti, L.

AU - Borra, G.

AU - D’Agostino, F.

AU - Rossi, V.

AU - Oscar, ALABISO

AU - Giorgio, BELLOMO

PY - 2011/1/1

Y1 - 2011/1/1

UR - https://iris.uniupo.it/handle/11579/29447

M3 - Contributo in Atti di Convegno

T2 - IFCC-WorldLab 21st International Congress of Clinical Chemistry and Laboratory Medicine

Y2 - 1 January 2011

ER -